Overall Status

Completed (124)

Recruiting (24)

Unknown status (20)

Not yet recruiting (11)

Active, not recruiting (9)

Terminated (7)

Withdrawn (5)

Enrolling by invitation (2)

Suspended (1)

Phase

n/a (49)

phase 4 (32)

phase 3 (31)

phase 2 (23)

phase 1 (17)

phase 2/phase 3 (8)

early phase 1 (6)

phase 1/phase 2 (5)

Study Documents

Annotated Case Report Form (1)

Assessment report: Eurartesim - dihydroartemisinin / piperaquine phosphate EMEA/H/C/1199 (1)

Clinical Study Report (1)

Dataset Specification (1)

Individual Participant Data Set (1)

Informed Consent Form (1)

Statistical Analysis Plan (1)

Study Protocol (1)

Intervention Type

drug (137)

other (29)

biological (17)

device (8)

behavioral (5)

diagnostic test (5)

procedure (3)

combination product (2)

dietary supplement (1)

Funder Type

Other (173)

Industry (20)

U.S. Fed (6)

NIH (4)

Study Type

Interventional (171)

Observational (27)

Observational [Patient Registry] (5)

Antimalarials

Showing 201 - 203 of 203

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Malaria Trial in Faladje (chlorproguanil-dapsone)

Suspended

Malaria

chlorproguanil-dapsone

Faladje, Mali

Faladje Missionary Dispensary

Aug 14, 2006

Falciparum Malaria, Vivax Malaria Trial in Timika (Chloroquine and sulphadoxine-pyrimethamine)

Completed

Falciparum Malaria
Vivax Malaria

Chloroquine and sulphadoxine-pyrimethamine

Timika, Papua, Indonesia

SP9 & SP12 Public Health- Malaria control clinics

Sep 7, 2005

Malaria Trial in Lambaréné (Fosmidomycin-clindamycin)

Completed

Malaria

Fosmidomycin-clindamycin

Lambaréné, Moyen Ogooué, Gabon

Medical Research Unit, Lambaréné

Sep 19, 2005